Opioid system diversity in developing neurons, astroglia, and oligodendroglia in the subventricular zone and striatum: Impact on gliogenesis in vivo

GLIA

Volumn 36, Issue 1, 2001, Pages 78-88

  Gobin, Sam J P ^a,b   Montagne, Lisette ^a   Van Zutphen, Marlijn ^a   Van Valk, Paul Der ^a   Van Den Elsen, Peter J ^a   De Groot, Corline J A ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

opioid receptors; opioid receptors; opioid receptors; Astrocytes; Cell division; Central nervous system development; Drug abuse; Glial fibrillary acidic protein; Oligodendrocytes; Opiate drug abuse; S100 ; Striatum; Subventricular zone

Indexed keywords

BROXURIDINE; CALCIUM BINDING PROTEIN; DIFFERENTIATION ANTIGEN; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUTAMATE TRANSPORTER; MEMBRANE ANTIGEN; MORPHINE; NALTREXONE; NERVE GROWTH FACTOR; OLIGODENDROCYTE O ANTIGEN, MOUSE; OPIATE PEPTIDE; OPIATE RECEPTOR; PROTEIN S 100; S 100 CALCIUM BINDING PROTEIN BETA SUBUNIT; S-100 CALCIUM-BINDING PROTEIN BETA SUBUNIT;

AGING; ANIMAL; ARTICLE; ASTROCYTE; CELL DIFFERENTIATION; CELL DIVISION; COMPARATIVE STUDY; CYTOLOGY; DRUG EFFECT; GROWTH, DEVELOPMENT AND AGING; HISTOLOGY; IMMUNOHISTOCHEMISTRY; INSTITUTE FOR CANCER RESEARCH MOUSE; LATERAL BRAIN VENTRICLE; METABOLISM; MOUSE; NEOSTRIATUM; NERVE CELL; NEWBORN; OLIGODENDROGLIA; PHYSIOLOGY;

AGING; AMINO ACID TRANSPORT SYSTEM X-AG; ANIMALS; ANIMALS, NEWBORN; ANTIGENS, DIFFERENTIATION; ANTIGENS, SURFACE; ASTROCYTES; BROMODEOXYURIDINE; CALCIUM-BINDING PROTEINS; CELL DIFFERENTIATION; CELL DIVISION; GLIAL FIBRILLARY ACIDIC PROTEIN; IMMUNOHISTOCHEMISTRY; LATERAL VENTRICLES; MICE; MICE, INBRED ICR; MORPHINE; NALTREXONE; NEOSTRIATUM; NERVE GROWTH FACTORS; NEURONS; OLIGODENDROGLIA; OPIOID PEPTIDES; RECEPTORS, OPIOID; S100 PROTEINS;

EID: 0034788552     PISSN: 08941491     EISSN: None     Source Type: Journal    
DOI: 10.1002/glia.1097     Document Type: Article

References (70)

1. S100β expression in and effects on microglia
2. Distribution and targeting of a μ-opioid receptor (MOR1) in brain and spinal cord
3. Multiple and novel specificities of monoclonal antibodies O1, O4, and R-mab used in the analysis of oligodendrocyte development
4. Transient expression of opioid receptors in defined regions of developing brain: Are embryonic receptors selective
5. Beta-endorphin is a potent inhibitor of thymidine incorporation into DNA via mu- and kappa-opioid receptors in fetal rat brain cell aggregates in culture
6. 2+ mobilization in rat C6 glioma cells
7. Central administration of morphine inhibits brain and liver ornithine decarboxylase activity in neonatal rats: Involvement of transcription- and non-transcription-dependent mechanisms
8. Brain cholecystokinin and β-endorphin systems may antagonistically interact to regulate tissue DNA synthesis in rat pups
9. Mitogenic signaling via endogenous kappa-opioid receptors in C6 glioma cells: Evidence for the involvement of protein kinase C and the mitogen-activated protein kinase signaling cascade
10. Mu-opioid agonist inhibition of kappa-opioid receptor-stimulated extracellular signal-regulated kinase phosphorylation is dynamin-dependent in C6 glioma cells
11. Differential time-course decreases in nonselective, mu-, delta-, and kappa-opioid receptors after focal cerebral ischemia in mice
12. Endothelins control the timing of Schwann cell generation in vitro and in vivo
13. Evidence for a kappa-opioid receptor on pituitary astrocytes: An autoradiographic study
14. Kappa opioid receptors in human microglia down regulate human immunodeficiency virus 1 expression
15. U50,488 protection against HIV-1-related neurotoxicity: Involvement of quinolinic acid suppression
16. Effects of acute and chronic administration of leu-enkephalin on cultured serotonergic neurons: Evidence for opioids as inhibitory neuronal growth factors
17. 3H-thymidine incorporation in the subependyma of the rat: An autoradiographic study
18. Expression of glutamate transporters in rat optic nerve oligodendrocytes
19. Functional roles of S100 proteins, calcium binding proteins of the EF-hand type
20. Immunohistochemical localization of the S-100 beta protein in postnatal cat visual cortex: Spatial and temporal patterns of expression in cortical and subcortical glia
21. Opiates inhibit neurogenesis in the adult rat hippocampus
22. δ and kappa opiate receptors in primary astroglial cultures from rat cerebral cortex
23. δ and kappa opiate receptors in primary astroglial cultures. Part II. Receptor sets in cultures from various brain regions and interactions with β-receptor activated cyclic AMP
24. Distinct distributions of mu, delta and kappa opioid receptor mRNA in rat brain
25. 2+ mobilization, development, and the antiproliferative effect of opioids
26. Opiates and the regulation of nervous system development: Evidence from in vitro studies
27. Endogenous opioid systems and the regulation of dendritic growth and spine formation
28. 2+-dependent mechanism
29. Dynorphin A (1-13) neurotoxicity in vitro: Opioid and non-opioid mechanisms in spinal cord neurodegeneration
30. Opioids intrinsically inhibit the genesis of mouse cerebellar granule cell precursors in vitro: Differential impact of μ and δ receptor activation on proliferation and neurite elongation
31. 2+ binding S100 proteins in the central nervous system
32. Pharmacological properties of a proenkephalin A-derived opioid peptide: BAM 18
33. Coregulation of neurite outgrowth and cell survival by amphoterin and S100 proteins through receptor for advanced glycation end products (RAGE) activation
34. Weaning-induced development of delta-opioid receptors in rat brain: Differential effects of guanine nucleotides and sodium upon ligand-receptor recognition
35. Endogenous opioid system in developing normal and jimpy oligodendrocytes: μ and κ opioid receptors mediate differential mitogenic and growth responses
36. Postnatal development of multiple opioid receptors in rat brain
37. Effects of morphine on DNA synthesis in neonatal rat brain
38. Gliogenesis in the central nervous system
39. Opioid receptor and peptide mRNA expression in proliferative zones of fetal rat central nervous system
40. Development of multiple opioid receptors
41. Glial and neuronal opioid receptors: Apparent positive cooperativity observed in intact cultured cells
42. Opioid peptides activate phospholipase D and protein kinase C-e in chicken embryo neuron cultures
43. Identification and differential regional expression of KOR-3/ORL-1 gene splice variants in mouse brain
44. Expression of mu, kappa, and delta opioid receptor messenger RNA in the human CNS: A 33P in situ hybridization study
45. Differential postnatal development of μ-, δ- and kappa-opioid binding sites in rat brain
46. Transient expression of the glial glutamate transporters GLAST and GLT in hippocampal neurons in primary culture
47. mu-opioid receptor activates signaling pathways implicated in cell survival and translational control
48. Opioids modulate cell division in the germinal zone of the late embryonic neocortex
49. S100 protein expression in subpopulations of neurons of rat brain
50. Evidence for four opioid kappa binding sites in guinea pig brain
51. Primary astroglial cultures derived from several rat brain regions differentially express μ, δ and kappa opioid receptor mRNA
52. Long-lasting effects of naltrexone, an opioid receptor antagonist, on cell proliferation in developing rat forebrain
53. Analysis of AMPA receptor properties during postnatal development of mouse hippocampal astrocytes
54. Differential ontegeny of multiple opioid receptors (mu, delta and kappa)
55. Opioid-dependent growth of glial cultures: Suppression of astrocyte DNA synthesis by Met-enkephalin
56. Glial growth is regulated by agonists selective for multiple opioid receptor types in vitro
57. Regional, developmental, and cell cycle-dependent differences in μ, δ, and κ opioid receptor expression among cultured mouse astrocytes
58. Differential postnatal development of μ, δ and κ-opioid binding sites in mouse brain
59. Long-term alterations in opiate antinociception resulting from infant fentanyl tolerance and dependence
60. Kappa opioids: Therapeutic considerations in epilepsy and CNS injury
61. Regulation of kappa-opioid receptor mRNA level by cyclic AMP and growth factors in cultured rat glial cells
62. Down-regulation of mu-opioid receptor expression in rat oligodendrocytes during their development in vitro
63. 5-enkephalinamide treatment on the DNA synthesis in the developing rat brain
64. Localization of epidermal growth factor receptors and putative neuroblasts in human subependymal zone
65. 85s6k S6 kinase
66. Increased brain size and cellular content in infant rats treated with an opioid antagonist
67. Identification of opioid peptides regulating proliferation of neurons and glia in the developing nervous system
68. Buffered picric acid formaldehyde: A new rapid fixative for electron microscopy
69. Developmental expression of the mu, kappa, and delta opioid receptor mRNAs in mouse
70. Expression of opioid receptors and ligands in pregnant mouse uterus and placenta